Skip to main content Accessibility help
×
Home

Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests

  • Jordi A. Matias-Guiu (a1), Ana Cortés-Martínez (a1), Maria Valles-Salgado (a1), Teresa Rognoni (a1), Marta Fernández-Matarrubia (a1), Teresa Moreno-Ramos (a1) and Jorge Matías-Guiu (a1)...

Abstract

Background:

Addenbrooke's Cognitive Examination III (ACE-III) is a screening test that was recently validated for diagnosing dementia. Since it assesses attention, language, memory, fluency, and visuospatial function separately, it may also be useful for general neuropsychological assessments. The aim of this study was to analyze the tool's ability to detect early stages of Alzheimer's disease and to examine the correlation between ACE-III scores and scores on standardized neuropsychological tests.

Methods:

Our study included 200 participants categorized as follows: 25 healthy controls, 48 individuals with subjective memory complaints, 47 patients with amnestic mild cognitive impairment and 47 mild Alzheimer's disease, and 33 patients with other neurodegenerative diseases.

Results:

The ACE-III memory and language domains were highly correlated with the neuropsychological tests specific to those domains (Pearson correlation coefficient of 0.806 for total delayed recall on the Free and Cued Selective Reminding Test vs. 0.744 on the Boston Naming Test). ACE-III scores discriminated between controls and patients with amnestic mild cognitive impairment (AUC: 0.906), and between controls and patients with mild Alzheimer's disease (AUC: 0.978).

Conclusion:

Our results suggest that ACE-III is a useful neuropsychological test for assessing the cognitive domains of attention, language, memory, and visuospatial function. It also enables detection of Alzheimer's disease in early stages.

Copyright

Corresponding author

Correspondence should be addressed to: Jordi A. Matias-Guiu, Department of Neurology, Hospital Clinico San Carlos, San Carlos Institute for Health Research (IdISSC), Universidad Complutense, Calle Profesor Martin Lagos S/N, 28040, Madrid, Spain. Phone: +34676933312, +34913303511. Email: jordimatiasguiu@hotmail.com, jordi.matias-guiu@salud.madrid.org.

References

Hide All
Blesa, R. et al. (2001). Clinical validity of the “mini-mental state” for Spanish speaking communities. Neuropsychologia, 39, 11501157.
Crawford, S., Whitnall, L., Robertson, J. and Evans, J. J. (2012). A systematic review of the accuracy and clinical utility of the Addenbrooke's cognitive examination and the Addenbrooke's cognitive examination-revised in the diagnosis of dementia. International Journal of Geriatric Psychiatry, 27, 659669.
DeLong, E. R., DeLong, D. M. and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics, 44, 837844.
Elamin, M., Holloway, G., Bak, T. H. and Pal, S. (2015). The utility of the Addenbrooke's cognitive examination version three in early-onset dementia. Dementia and Geriatric Cognitive Disorders, 41, 915.
Gorno-Tempini, M. L. et al. (2011). Classification of primary progressive aphasia and its variants. Neurology, 76, 10061114.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 5662.
Hsieh, S. et al. (2015). The mini-Addenbrooke's cognitive examination: a new assessment tool for dementia. Dementia and Geriatric Cognitive Disorders, 39, 111.
Hsieh, S., Schubert, S., Hoon, C., Mioshi, E. and Hodges, J. R. (2013). Validation of the Addenbrooke's cognitive examination III in frontotemporal dementia and Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 36, 242250.
Jubb, M. and Evans, J. J. (2015). An investigation of the utility of the Addenbrooke's cognitive examination III in the early detection of dementia in memory clinic patients aged over 75 years. Dementia and Geriatric Cognitive Disorders, 40, 222232.
Lam, B. et al. (2013). Criterion and convergent validity of the montreal cognitive assessment with screening and standardized neuropsychological testing. Journal of the American Geriatrics Society, 61, 21812185.
Larner, A. and Mitchell, A. J. (2014). A meta-analysis of the accuracy of the Addenbrooke's cognitive examination (ACE) and the Addenbrooke's cognitive examination-revised (ACE-R) in the detection of dementia. International Psychogeriatrics, 26, 555563.
Leyton, C. E., Hornberger, M., Mioshi, E. and Hodges, J. R. (2010). Application of Addenbrooke's cognitive examination to diagnosis and monitoring of progressive primary aphasia. Dementia and Geriatric Cognitive Disorders, 29, 504509.
Litvan, I. et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Ricardson-Olszewski syndrome): report of the NINS-SPSP international workshop. Neurology, 47, 19.
Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W. and Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55, 16131620.
Matias-Guiu, J. A. et al. (2014). Evaluation of the new consensus criteria for the diagnosis of primary progressive aphasia using fluorodeoxyglucose positron emission tomography. Dementia and Geriatric Cognitive Disorders, 38, 147152.
Matías-Guiu, J. A. and Fernández-Bobadilla, R. (2014). Validation of the Spanish-language version of Mini-Addenbrooke's cognitive examination as a dementia screening tool. Neurología. doi:10.1016/j.nrl.2014.10.005.
Matías-Guiu, J. A., Fernández-Bobadilla, R. and Cortés-Martínez, A. (2016a). Addenbrooke's Cognitive Examination III: a neuropsychological test useful to screen and obtain a cognitive profile. Neurología. Epub ahead of print. doi: 10.1016/j.nrl.2016.06.014.
Matías-Guiu, J. A. et al. (2016b). Normative data for the Spanish version of the Addenbrooke's cognitive examination III. Dementia and Geriatric Cognitive Disorders, 41, 243250.
Matías-Guiu, J. A. et al. (2015). Validation of the Spanish version of Addenbrooke's cognitive examination III for diagnosing dementia. Neurología, 30, 545551.
McKeith, I. G. et al. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology, 65, 18631872.
McKhann, G. et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 263269.
Menon, R., Lekha, V., Justus, S., Sarma, P. and Mathuranath, P. (2014). A pilot study on utility of Malayalam version of Addenbrooke's cognitive examination in detection of amnestic mild cognitive impairment: a critical insight into utility of learning and recall measures. Annals of Indian Academy of Neurology, 17, 420425.
Morris, J. C. (1993). The clinical dementia rating (CDR): current version and scoring rules. Neurology, 43, 24122414.
Pedro, M. C., Mercedes, M. P., Ramón, L. H. and Borja, M. R. (2016). Subjective memory complaints in elderly: relationship with health status, multimorbidity, medications, and use of services in a population-based study. International Psychogeriatrics. Epub ahead of print. doi: 10.1017/S104161021600106X.
Peña-Casanova, J. et al. (2009). Spanish multicenter normative studies (NEURONORMA project): methods and sample characteristics. Archives of Clinical Neuropsychology, 24, 307319.
Pfeffer, R. I., Kurosaki, T. T., Harrah, C. H. Jr., Chance, J. M. and Filos, S. (1982). Measurement of functional activities in older adults in the community. The Journal of Gerontology, 37, 323329.
Pigliautile, M. et al. (2011). Validation study of the Italian Addenbrooke's cognitive examination revised in a young-old and old-old population. Dementia and Geriatric Cognitive Disorders, 32, 301307.
Rascovsky, K. et al. (2011). Sensitivity of revised diagnostic criteria for the behavioral variant of frontotemporal dementia. Brain, 134, 24562477.
Sarazin, M. et al. (2007). Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology, 69, 18591867.

Keywords

Type Description Title
WORD
Supplementary materials

Matias-Guiu supplementary material
Table S1

 Word (128 KB)
128 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed